CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

NCT00333190 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy
AML
ALL
CML
Multiple Myeloma
NHL
Hodgkin's Lymphoma

Interventions

DEVICE: CD+8 T cell depletion

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]